Skip to main content
S&P 5007,651.54-0.25%DOW50,906.05-0.86%NASDAQ26,861.06+0.24%BTC$83,704.00+0.37%ETH$2,683.29+0.17%GOLD$4,189.10+0.22%OIL$90.34+1.07%
Smart Investors Daily
SID Premium
Tenon Medical, Inc. logo

NASDAQ · TNON

Tenon Medical, Inc.

Healthcare · Medical - Devices

$2.73

Up+$1.30 (+47.62%)

Updated Sep 30, 2026, 7:41 PM

SID Score

5.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
9.87M
P/E ratio
-0.74
Dividend yield
0.00%
52-week range
$0.18 – $17.84
Volume
283.56K
Avg. volume
419.87K

Price performance · TNON

TNON price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Sep 29, 2026

TNON closed at $2.73 after 20 trading sessions, down 39.60% for the selected period.

Last close
$2.73
Period change
-39.60%
Period low
$2.44
Period high
$5.93
Daily close
View OHLC price history
TNON OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 29, 2026$2.80$2.8793$2.67$2.73283.56K
Sep 28, 2026$3.025$3.05$2.86$2.86198.38K
Sep 25, 2026$2.95$3.18$2.94$3.131.74M
Sep 24, 2026$3.18$3.2648$2.95$2.96364.32K
Sep 23, 2026$3.36$3.42$3.25$3.27218.07K
Sep 22, 2026$3.63$3.665$3.41$3.43567.24K
Sep 21, 2026$4.04$4.08$3.70$3.73518.79K
Sep 18, 2026$4.20$4.23$3.9897$4.08497.81K
Sep 17, 2026$4.06$4.2422$3.85$4.201.06M
Sep 16, 2026$5.20$5.31$3.79$3.912.37M
Sep 15, 2026$6.335$6.88$4.92$5.0611.72M
Sep 14, 2026$5.565$6.39$5.32$5.565.01M
Sep 11, 2026$8.14$10.84$5.23$5.93108.58M
Sep 10, 2026$4.20$5.9599$3.96$5.30127.15M
Sep 9, 2026$3.44$3.67$2.40$2.4412.72M
Sep 8, 2026$3.58$3.60$3.1793$3.36385.67K
Sep 4, 2026$3.76$3.77$3.62$3.7294.23K
Sep 3, 2026$4.38$4.4504$3.6801$3.77150.41K
Sep 2, 2026$4.56$4.79$4.3985$4.4783.69K
Sep 1, 2026$4.46$4.75$4.43$4.52121.57K

Latest TNON news

The latest Smart Investors Daily articles mentioning TNON.

Stock researchCompany · Overview

TNON research

Overview

Company profile and research snapshot.

Company profile

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
TNON recent ratings
DateFirmRatingTarget
Apr 9, 2025Alliance Global PartnersBuy—
Nov 15, 2024Maxim GroupBuy—
Aug 14, 2024BenchmarkSpeculative Buy—
Apr 15, 2024BenchmarkSpeculative Buy—
Mar 10, 2023BenchmarkBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 14, 2026

WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ: TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders has closed its previously announced warrant inducement agreement with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the

Yahoo · Sep 14, 2026

Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338

LOS GATOS, CA / ACCESS Newswire / September 14, 2026 / , Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced today it has closed its previously announced warrant inducement agreement with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants").

Yahoo · Sep 11, 2026

WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants").

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By